Laparoscopic and open postchemotherapy retroperitoneal lymph node dissection in patients with advanced testicular cancer – a single center analysis

Table 6 Outcome characteristics

Variable	L-PCLND	O-PCLND	p Value
Variable	N = 46	N = 21	p Value
Median follow up; months (IQR)	30.1 (12.1 – 47.1)	54.5 (22.0 – 87.7)	0.033 *¹
Further treatment, n (%)
surveillance	33 (71.7)	12 (57.1)	0.020 *²
chemotherapy	3 (6.5)	6 (28.5)
thoracotomy	0 (0)	1 (4.8)
incomplete follow up	9 (19.6)	0 (0)	0.048 *²
Lost to follow up	1 (2.2)	2 (9.5)	0.229 *²
Tumor relapse, n (%)	4 (8.6)	3 (14.2)	0.415 *²
Estimated OS since PCLND in months
Mean ± SD	83.3 ± 1.9	95.0 ± 7.4	0.447 *³
(95%CI; range)	(79.6 - 87.3)	(80.5 – 109.6)

Abbreviations
L-PCLND – laparoscopic postchemotherapy retroperitoneal lymph node dissection; O-PCLND – open postchemotherapy retroperitoneal lymph node dissection; OS – overall survival; SD – standard deviation; n.s. - not statistically significant; *¹ – Mann–Whitney U test *² – fishers exact test; *³ – log-rank test.

ISSN: 1471-2490